Arvinas Inc.

NASDAQ: ARVN · Real-Time Price · USD
7.29
0.60 (8.97%)
At close: May 28, 2025, 3:59 PM
7.22
-1.03%
Pre-market: May 29, 2025, 04:22 AM EDT
8.97%
Bid 7.18
Market Cap 532.47M
Revenue (ttm) 426.9M
Net Income (ttm) -46.6M
EPS (ttm) -0.66
PE Ratio (ttm) -11.05
Forward PE -2.04
Analyst Buy
Ask 7.69
Volume 3,571,002
Avg. Volume (20D) 3,026,565
Open 6.70
Previous Close 6.69
Day's Range 6.75 - 7.50
52-Week Range 5.90 - 35.34
Beta 2.23

About ARVN

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ARVN
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ARVN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
4 weeks ago
-24.84%
Arvinas shares are trading lower. The company repo... Unlock content with Pro Subscription
2 months ago
-52.73%
Arvinas shares are trading lower after the company announced topline results from the phase 3 VERITAC-2 Trial of Vepdegestrant Monotherapy Versus Fulvestrant in adults with advanced or retastatic breast cancer.